NURSING PHARMACOLOGY Med-surg Nursing

시작하기. 무료입니다
또는 회원 가입 e메일 주소
NURSING PHARMACOLOGY Med-surg Nursing 저자: Mind Map: NURSING PHARMACOLOGY Med-surg Nursing

1. Surgical Nursing

1.1. Pre-Op work up

1.2. Post-Op Complications/Care

1.3. Bowel Obstructions

2. Endocrine Disorders

2.1. Type 1 Diabetes

2.2. Type 2 Diabetes

2.3. Diabetes Isipidus

2.4. Syndrome of Inappropriate Antidiuretic Hormone

2.5. Addison's Disease

2.6. Cushing's Syndrome

3. Vitamins and Minerals

3.1. VITAMINS

3.1.1. FAT-SOLUBLE VITAMINS

3.1.1.1. A

3.1.1.2. D

3.1.1.3. E

3.1.1.4. K

3.1.2. WATER-SOLUBLE VITAMINS

3.1.2.1. B Complex

3.1.2.2. C

3.2. COMMON MINERALS

3.2.1. Iron

3.2.2. Calcium

3.2.3. Phosphorus

3.2.4. Magnesium

3.2.5. Sodium

3.2.6. Potassium

3.2.7. Zinc

4. Antimicrobial Agents

4.1. ANTIBACTERIAL AGENTS

4.1.1. Penicillins

4.1.2. Cephalosporins

4.1.3. Aminogylcosides

4.1.4. Fluoroquinolones

4.1.5. Macrolides

4.1.6. Tetracyclines

4.1.7. Sulphonamides

4.2. ANTIVIRAL AGENTS

4.3. ANTITUBERCULAR AGENTS

4.4. ANTIFUNGAL AGENTS

4.5. ANTIPROTOZOAL AGENTS/ ANTIMALARIALS

4.6. ANTHELMINTIC AGENTS

4.7. ANTISEPTICS AND DISINFECTANTS

5. Drugs That Affect the Respiratory System

5.1. ANTITUSSIVES

5.1.1. Opioids

5.1.2. Nonopioids

5.2. EXPECTORANTS

5.3. DECONGESTANTS

5.3.1. Common Sympathomimetics

5.3.2. Corticosteroids

5.4. MUCOLYTICS

5.5. ANTIHISTAMINES

5.6. CORTICOSTEROIDS

5.7. BRONCHODILATORS

5.7.1. Beta Adrenergics

5.7.2. Anticholinergics

5.7.3. Xanthine Derivatives

5.7.4. Leukotriene Modifiers

5.7.5. Mast Cell Stabilizers

6. Respiratory Disorders

6.1. Asthma

6.2. Pulmonary Embolus

6.3. Pulmonary Edema

6.4. Chronic Obstructive Pulmonary Disease

6.5. Tuberculosis

6.6. Acute Respiratory Distress Syndrome

6.7. Acute Respiratory Failure

6.8. Atelectasis

6.9. Pneumothorax

6.10. Lung Cancer

7. Drugs That Affect the Urinary System

7.1. DIURETICS

7.1.1. Carbonic Anhydrase Inhibitors

7.1.2. Loop Diuretics

7.1.3. Osmotic Diuretics

7.1.4. Potassium-Sparing Diuretics

7.1.5. Thiazides and Thiazidelike Diuetics

7.2. URINARY ANAESTHETICS

7.3. SMOOTH MUSCULAR STIMULANTS (CHOLINERGICS)

8. Renal Disorders

8.1. Urinary Tract Infections

8.2. Pyelonephritis

8.3. Nephrotic Syndrome

8.4. Glomerulonephritis

8.5. Urinary Tract Calculi

8.6. Polycystic Kidney Disease

8.7. Acute Renal Failure

8.8. Chronic Renal Failure

8.9. Dialysis

9. DVT

9.1. Heparin

9.1.1. Decrease clotting cascade; check aPTT

9.1.2. Therapeutic range of aPTT on Heparin: 50-80 sec (Normal aPTT 30-40sec)

9.2. Warfarin (Coumadin)

9.2.1. Antagonizes Vitamin K; check PT & INR

9.2.2. INR Target Range: 2-3 during treatment (get checked once a month)

9.3. Enoxaparin (Lovenox)

9.3.1. Low molecular weight heparin; providing anticoagulation action

9.4. Signs & Symptoms of DVT

9.4.1. Pain, swelling, Positive Homan's sign, red & warm leg, dilated veins, low grade fever I.e. 100.4F, unequal leg measurements

10. Pulmonary Embolism

10.1. Pathophysiology: a thrombus in a lower extremity moves out of its localized position

10.2. Signs & Symptoms: (MOST COMMON) no hx, unexplained Dyspnea, tachycardia, tachypnea, (other s/s): chest pain, cough, crackles, fever, decreased mental status, decreased O2 stats

10.3. Complications: Pulmonary Infarction & Pulmonary HTN

10.4. Nursing Care: Bed rest with HOB Elevated, IV Heparin Drip or Lovenox, Monitor Coagulation Studies q 6 Hours, O2 Therapy- started even before vitals if PE is being assessed, Pulse Oximetry, Pain Medications – Morphine IVP Anti-anxiety Medications, Same Patient Teaching as DVT, Treat Atrial Fibrillation of high rate with Digoxin, Monitor for Bleeding from Body Orifices

11. Sepsis

11.1. Signs & Symptoms: Infection, documented or suspected, and some of the following. General Variables • Fever (temperature >100.9° F [38.3° C]) • Hypothermia (core temperature <97.0° F [36° C]) • Heart rate >90 beats/min • Tachypnea • Altered mental status • Significant edema or positive fluid balance (>20 mL/kg over 24 hr) • Hyperglycemia (blood glucose >140 mg/dL) in the absence of diabetes Inflammatory Variables • Leukocytosis (WBC count >12,000/µL) • Leukopenia (WBC count <4000/µL) • Normal WBC count with >10% immature forms • Elevated C-reactive protein • Elevated procalcitonin Hemodynamic Variables • Arterial hypotension (SBP <90 mm Hg, MAP <70 mm Hg, or a decrease in SBP >40 mm Hg) Organ Dysfunction Variables • Arterial hypoxemia (PaO2/FIO2 <300) • Acute oliguria (urine output <0.5 mL/kg/hr for at least 2 hr despite adequate fluid resuscitation) • Serum creatinine increase >0.5 mg/dL • Coagulation abnormalities (INR >1.5 or PTT >60 sec) • Ileus (absent bowel sounds) • Thrombocytopenia (platelet count <100,000/µL) • Hyperbilirubinemia (total bilirubin >4 mg/dL) Tissue Perfusion Variables • Hyperlactatemia (>1 mmol/L) • Decreased capillary refill or mottling

11.2. Sepsis Shock Def: Septic shock is the presence of sepsis with hypotension despite adequate fluid resuscitation, along with inadequate tissue perfusion resulting in tissue hypoxia. The main organisms that cause sepsis are gram-negative and gram-positive bacteria. Parasites, fungi, and viruses can also cause sepsis and septic shock.

12. Drugs That Affect the Gastrointestinal System

12.1. LAXATIVES

12.1.1. Bulk Forming

12.1.2. Emollient

12.1.3. Stimulant

12.1.4. Hyperosmotic

12.2. ANTIDIARRHEALS

12.2.1. Opioids

12.2.2. Bulk Forming

12.2.3. Absorbents

12.2.4. Anticholinergics

12.3. ANTACIDS

12.3.1. Neutralizing Agents

12.3.2. H2 Receptor Antagonists

12.3.3. Proton Pump Inhibitors

12.3.4. Muscosal Protective Agents

12.4. ANTIEMETICS

12.4.1. Anticholinergics

12.4.2. Antihistamines

12.4.3. Neuroleptics

12.4.4. Prokinetics

12.4.5. Serotonin Blockers

12.4.6. Cannabis

13. Drugs That Affect the Cardiovascular System

13.1. BLOOD/COAGULATION

13.1.1. Anticoagulants

13.1.1.1. Heparin

13.1.1.2. Warfarin

13.1.1.3. Antiplatelet Drugs

13.1.2. Fibrinolytics

13.1.3. Antilipemics

13.1.4. Antianemics

13.2. BLOOD VESSELS

13.2.1. Antihypotensives

13.2.2. Antihypertensives

13.3. HEART

13.3.1. Cardiotonics (Inotropics)

13.3.2. Antidysrhythmics

13.3.3. Anti-Angina Pectoris Drugs

14. Antineoplastic Agents

14.1. Alkylating Agents

14.2. Antimetabolites

14.3. Mitotic Inhibitors

14.4. Antitumor Antibiotics

14.5. Topoisomerase-1 Inhibitors

14.6. Hormonal Antagonists

14.7. Biological Response Modifiers

15. Oncological Disorders

15.1. Cancer

15.2. Leukemia

15.3. Hodgkin's Disease

15.4. Breast Cancer

15.5. Ovarian Cancer

15.6. Prostate Cancer

15.7. Testicular Cancer

16. Drugs That Affect the Nervous System

16.1. Central Nervous System

16.1.1. DEPRESSANTS

16.1.1.1. Analgesics - Opioids

16.1.1.1.1. Opioid Antagonists

16.1.1.1.2. Nonopioids

16.1.1.2. Sedatives, Hypnotics, Anxiolytic Agents

16.1.1.2.1. Barbiturates

16.1.1.2.2. Benzodiazepines

16.1.1.2.3. NonBenzodiazepines

16.1.1.3. Antiseizure Agents

16.1.1.3.1. Barbiturates

16.1.1.3.2. Benzodiazepines

16.1.1.3.3. Hydantoins

16.1.1.3.4. Carbamazepines

16.1.1.3.5. Valproic Acid

16.1.1.4. Anti-Parkinson Drugs

16.1.1.4.1. Dopaminergics

16.1.1.4.2. Anticholinergics

16.1.1.5. Skeletal Muscle Relaxants

16.1.2. Psychotropic Drugs

16.1.2.1. Antidepressants

16.1.2.2. Mood Stabilizers

16.1.2.3. Antipsychotics

16.1.3. Anaesthetics

16.1.3.1. Locally Acting

16.1.3.2. General (Systemic)

16.1.3.3. Neuromuscular Blocking Agents

16.1.4. Stimulants

16.1.4.1. Amphetamines

16.2. Autonomic Nervous System

16.2.1. SYMPATHETIC DIVISION

16.2.1.1. Adrenergics

16.2.1.2. Antiadrenergics or Adrenergic Blocking Agents

16.2.2. PARASYMPATHETIC DIVISION

16.2.2.1. Cholinergics

16.2.2.2. Anticholinergics

17. Neurological/ Musculoskeletal Diseases

17.1. Multiple Sclerosis (MS)

17.2. Parkinson's Disease

17.3. Spinal Cord Injury

17.4. Osteomyelitis

17.5. Osteoporosis

17.6. Fibromyalgia Syndrome

17.7. Chronic Fatigue Syndrome

17.8. Osteoarthritis

17.9. Rheumatoid Arthritis

17.10. Systemic Lupus Erythematosus

17.11. Trauma, Burns, Fractures

17.12. Head Injury

17.12.1. Subarachnoid Hemorrhage

18. Cardiovascular Disorders

18.1. Brain Attack - TIA

18.2. Hypertension

18.3. Coronary Artery Disease (CAD)

18.3.1. Angina

18.3.2. Myocardial Infarction (MI)

18.3.3. Sudden Cardiac Death

18.4. Valvular Heart Disease

18.5. Dysrhythmias

18.6. Peripheral Vascular Disease

18.7. Abdominal Aortic Aneurysm (AAA)

18.8. Heart Failure

18.9. Shock

18.9.1. Anaphylactic

18.9.2. Cardiogenic

18.9.3. Septic

18.10. Hypovolemia

18.11. Cardiopulmonary Arrest

19. GI System Disorders

19.1. Peptic Ulcer Disease

19.2. Gastroesophageal Reflux (GERD)

19.3. Gastritis

19.4. Appendicitis

19.5. Diverticulitis

19.6. Inflammatory Bowel Disease

19.7. Ulcerative Colitis

19.8. Crohn's Disease

19.9. Colorectal Cancer

19.10. Jaundice

19.11. Cholelithiasis

19.12. Hepatitis

19.13. Cirrhosis

19.14. Pancreatitis

20. Lab Values

20.1. Anemia